These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 18641537
1. Glutathione S-transferase polymorphisms are not associated with population pharmacokinetic parameters of busulfan in pediatric patients. Zwaveling J, Press RR, Bredius RG, van Derstraaten TR, den Hartigh J, Bartelink IH, Boelens JJ, Guchelaar HJ. Ther Drug Monit; 2008 Aug; 30(4):504-10. PubMed ID: 18641537 [Abstract] [Full Text] [Related]
2. Influence of glutathione S-transferase A1, P1, M1, T1 polymorphisms on oral busulfan pharmacokinetics in children with congenital hemoglobinopathies undergoing hematopoietic stem cell transplantation. Elhasid R, Krivoy N, Rowe JM, Sprecher E, Adler L, Elkin H, Efrati E. Pediatr Blood Cancer; 2010 Dec 01; 55(6):1172-9. PubMed ID: 20672371 [Abstract] [Full Text] [Related]
3. Influence of GST gene polymorphisms on busulfan pharmacokinetics in children. Ansari M, Lauzon-Joset JF, Vachon MF, Duval M, Théoret Y, Champagne MA, Krajinovic M. Bone Marrow Transplant; 2010 Feb 01; 45(2):261-7. PubMed ID: 19584821 [Abstract] [Full Text] [Related]
4. Influence of GST gene polymorphisms on the clearance of intravenous busulfan in adult patients undergoing hematopoietic cell transplantation. Kim SD, Lee JH, Hur EH, Lee JH, Kim DY, Lim SN, Choi Y, Lim HS, Bae KS, Noh GJ, Yun SC, Han SB, Lee KH. Biol Blood Marrow Transplant; 2011 Aug 01; 17(8):1222-30. PubMed ID: 21215809 [Abstract] [Full Text] [Related]
5. Influence of glutathione S-transferase A1 polymorphism on the pharmacokinetics of busulfan. Kusama M, Kubota T, Matsukura Y, Matsuno K, Ogawa S, Kanda Y, Iga T. Clin Chim Acta; 2006 Jun 01; 368(1-2):93-8. PubMed ID: 16448639 [Abstract] [Full Text] [Related]
7. Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies. Tran HT, Madden T, Petropoulos D, Worth LL, Felix EA, Sprigg-Saenz HA, Choroszy M, Danielson M, Przepiorka D, Chan KW. Bone Marrow Transplant; 2000 Sep 01; 26(5):463-70. PubMed ID: 11019834 [Abstract] [Full Text] [Related]
8. Effect of genetic polymorphisms in genes encoding GST isoenzymes on BU pharmacokinetics in adult patients undergoing hematopoietic SCT. ten Brink MH, Wessels JA, den Hartigh J, van der Straaten T, von dem Borne PA, Guchelaar HJ, Zwaveling J. Bone Marrow Transplant; 2012 Feb 01; 47(2):190-5. PubMed ID: 21441958 [Abstract] [Full Text] [Related]
9. Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation. Tran H, Petropoulos D, Worth L, Mullen CA, Madden T, Andersson B, Choroszy M, Nguyen J, Webb SK, Chan KW. Biol Blood Marrow Transplant; 2004 Nov 01; 10(11):805-12. PubMed ID: 15505611 [Abstract] [Full Text] [Related]
10. Effect of glutathione S-transferase genetic polymorphisms on busulfan pharmacokinetics and veno-occlusive disease in hematopoietic stem cell transplantation: A meta-analysis. Kim MG, Kwak A, Choi B, Ji E, Oh JM, Kim K. Basic Clin Pharmacol Toxicol; 2019 Jun 01; 124(6):691-703. PubMed ID: 30511436 [Abstract] [Full Text] [Related]
11. Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. Kim I, Keam B, Lee KH, Kim JH, Oh SY, Ra EK, Yoon SS, Park SS, Kim CS, Park S, Hong YC, Kim BK. Clin Transplant; 2007 Jun 01; 21(2):207-13. PubMed ID: 17425746 [Abstract] [Full Text] [Related]
12. Once-daily intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics and early clinical outcomes. Zwaveling J, den Hartigh J, Lankester AC, Guchelaar HJ, Egeler RM, Bredius RG. Anticancer Drugs; 2006 Oct 01; 17(9):1099-105. PubMed ID: 17001185 [Abstract] [Full Text] [Related]
13. Population pharmacokinetics of melphalan and glutathione S-transferase polymorphisms in relation to side effects. Kühne A, Sezer O, Heider U, Meineke I, Muhlke S, Niere W, Overbeck T, Hohloch K, Trümper L, Brockmöller J, Kaiser R. Clin Pharmacol Ther; 2008 May 01; 83(5):749-57. PubMed ID: 17914442 [Abstract] [Full Text] [Related]
14. Pharmacokinetic disposition and clinical outcomes in infants and children receiving intravenous busulfan for allogeneic hematopoietic stem cell transplantation. Schechter T, Finkelstein Y, Doyle J, Verjee Z, Moretti M, Koren G, Dupuis LL. Biol Blood Marrow Transplant; 2007 Mar 01; 13(3):307-14. PubMed ID: 17317584 [Abstract] [Full Text] [Related]
15. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients. Sreeja L, Syamala V, Hariharan S, Syamala VS, Raveendran PB, Sivanandan CD, Madhavan J, Ankathil R. J Exp Ther Oncol; 2008 Mar 01; 7(1):73-85. PubMed ID: 18472644 [Abstract] [Full Text] [Related]
16. Population pharmacokinetics of oral busulfan in children. Schiltmeyer B, Klingebiel T, Schwab M, Mürdter TE, Ritter CA, Jenke A, Ehninger G, Gruhn B, Würthwein G, Boos J, Hempel G. Cancer Chemother Pharmacol; 2003 Sep 01; 52(3):209-16. PubMed ID: 12811512 [Abstract] [Full Text] [Related]
17. Population pharmacokinetics of busulfan in children: increased evidence for body surface area and allometric body weight dosing of busulfan in children. Trame MN, Bergstrand M, Karlsson MO, Boos J, Hempel G. Clin Cancer Res; 2011 Nov 01; 17(21):6867-77. PubMed ID: 21918171 [Abstract] [Full Text] [Related]
18. Influence of GST polymorphisms on busulfan pharmacokinetics in Japanese children. Nishikawa T, Yamaguchi H, Ikawa K, Nakayama K, Higashi E, Miyahara E, Abematsu T, Nakagawa S, Kodama Y, Tanabe T, Shigemi A, Shinkoda Y, Okamoto Y, Takeda Y, Kawano Y. Pediatr Int; 2019 Jun 01; 61(6):558-565. PubMed ID: 30963629 [Abstract] [Full Text] [Related]